Literature DB >> 26968399

Differential effects of IGF-1 deficiency during the life span on structural and biomechanical properties in the tibia of aged mice.

Nicole M Ashpole1, Jacquelyn C Herron2, Patrick N Estep3, Sreemathi Logan4, Erik L Hodges4, Andriy Yabluchanskiy4, Mary Beth Humphrey2,5, William E Sonntag4.   

Abstract

Advanced aging is associated with the loss of structural and biomechanical properties in bones, which increases the risk for bone fracture. Aging is also associated with reductions in circulating levels of the anabolic signaling hormone, insulin-like growth factor (IGF)-1. While the role of IGF-1 in bone development has been well characterized, the impact of the age-related loss of IGF-1 on bone aging remains controversial. Here, we describe the effects of reducing IGF-1 at multiple time points in the mouse life span--early in postnatal development, early adulthood, or late adulthood on tibia bone aging in both male and female igf (f/f) mice. Bone structure was analyzed at 27 months of age using microCT. We find that age-related reductions in cortical bone fraction, cortical thickness, and tissue mineral density were more pronounced when IGF-1 was reduced early in life and not in late adulthood. Three-point bone bending assays revealed that IGF-1 deficiency early in life resulted in reduced maximum force, maximum bending moment, and bone stiffness in aged males and females. The effects of IGF-1 on bone aging are microenvironment specific, as early-life loss of IGF-1 resulted in decreased cortical bone structure and strength along the diaphysis while significantly increasing trabecular bone fraction and trabecular number at the proximal metaphysis. The increases in trabecular bone were limited to males, as early-life loss of IGF-1 did not alter bone fraction or number in females. Together, our data suggest that the age-related loss of IGF-1 influences tibia bone aging in a sex-specific, microenvironment-specific, and time-dependent manner.

Entities:  

Keywords:  IGF-1; MicroCT; Three-point bone bending; Tibia

Mesh:

Substances:

Year:  2016        PMID: 26968399      PMCID: PMC5005911          DOI: 10.1007/s11357-016-9902-5

Source DB:  PubMed          Journal:  Age (Dordr)        ISSN: 0161-9152


  66 in total

Review 1.  The anti-ageing action of dietary restriction.

Authors:  H Van Remmen; Z Guo; A Richardson
Journal:  Novartis Found Symp       Date:  2001

2.  Serum levels of insulin-like growth factor (IGF) I, IGF-binding protein (IGFBP)-2, and IGFBP-3 in osteoporotic patients with and without spinal fractures.

Authors:  T Sugimoto; K Nishiyama; F Kuribayashi; K Chihara
Journal:  J Bone Miner Res       Date:  1997-08       Impact factor: 6.741

3.  IGF-1 Signaling is Essential for Differentiation of Mesenchymal Stem Cells for Peak Bone Mass.

Authors:  Janet L Crane; Luo Zhao; Joseph S Frye; Lingling Xian; Tao Qiu; Xu Cao
Journal:  Bone Res       Date:  2013-06-28       Impact factor: 13.567

4.  Conditional deletion of insulin-like growth factor-I in collagen type 1alpha2-expressing cells results in postnatal lethality and a dramatic reduction in bone accretion.

Authors:  Kristen E Govoni; Jon E Wergedal; Lore Florin; Peter Angel; David J Baylink; Subburaman Mohan
Journal:  Endocrinology       Date:  2007-08-23       Impact factor: 4.736

5.  IGF-1R signaling in chondrocytes modulates growth plate development by interacting with the PTHrP/Ihh pathway.

Authors:  Yongmei Wang; Zhiqiang Cheng; Hashem Z Elalieh; Eiichiro Nakamura; Minh-Thanh Nguyen; Susan Mackem; Thomas L Clemens; Daniel D Bikle; Wenhan Chang
Journal:  J Bone Miner Res       Date:  2011-07       Impact factor: 6.741

6.  Reduced levels of serum IGF-1 is related to the presence of osteoporotic fractures in male idiopathic osteoporosis.

Authors:  Julien Paccou; Juliette Dewailly; Bernard Cortet
Journal:  Joint Bone Spine       Date:  2011-07-30       Impact factor: 4.929

Review 7.  Diverse roles of growth hormone and insulin-like growth factor-1 in mammalian aging: progress and controversies.

Authors:  William E Sonntag; Anna Csiszar; Raphael deCabo; Luigi Ferrucci; Zoltan Ungvari
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2012-04-20       Impact factor: 6.053

8.  Normal growth and development in the absence of hepatic insulin-like growth factor I.

Authors:  S Yakar; J L Liu; B Stannard; A Butler; D Accili; B Sauer; D LeRoith
Journal:  Proc Natl Acad Sci U S A       Date:  1999-06-22       Impact factor: 11.205

9.  Serum IGF-1 is insufficient to restore skeletal size in the total absence of the growth hormone receptor.

Authors:  Yingjie Wu; Hui Sun; Jelena Basta-Pljakic; Luis Cardoso; Oran D Kennedy; Hector Jasper; Horacio Domené; Liliana Karabatas; Clara Guida; Mitchell B Schaffler; Clifford J Rosen; Shoshana Yakar
Journal:  J Bone Miner Res       Date:  2013-07       Impact factor: 6.741

10.  Relationship between insulin, insulin-like growth factor I, and dehydroepiandrosterone sulfate concentrations during childhood, puberty, and adult life.

Authors:  C P Smith; D B Dunger; A J Williams; A M Taylor; L A Perry; E A Gale; M A Preece; M O Savage
Journal:  J Clin Endocrinol Metab       Date:  1989-05       Impact factor: 5.958

View more
  9 in total

1.  IGF-1 has sexually dimorphic, pleiotropic, and time-dependent effects on healthspan, pathology, and lifespan.

Authors:  Nicole M Ashpole; Sreemathi Logan; Andriy Yabluchanskiy; Matthew C Mitschelen; Han Yan; Julie A Farley; Erik L Hodges; Zoltan Ungvari; Anna Csiszar; Sixia Chen; Constantin Georgescu; Gene B Hubbard; Yuji Ikeno; William E Sonntag
Journal:  Geroscience       Date:  2017-04-13       Impact factor: 7.713

Review 2.  The Somatotropic Axis in Human Aging: Framework for the Current State of Knowledge and Future Research.

Authors:  Sofiya Milman; Derek M Huffman; Nir Barzilai
Journal:  Cell Metab       Date:  2016-06-14       Impact factor: 27.287

3.  IGF1R signaling regulates astrocyte-mediated neurovascular coupling in mice: implications for brain aging.

Authors:  Stefano Tarantini; Priya Balasubramanian; Andriy Yabluchanskiy; Nicole M Ashpole; Sreemathi Logan; Tamas Kiss; Anna Ungvari; Ádám Nyúl-Tóth; Michal L Schwartzman; Zoltan Benyo; William E Sonntag; Anna Csiszar; Zoltan Ungvari
Journal:  Geroscience       Date:  2021-03-06       Impact factor: 7.713

Review 4.  Insulin-like growth factors: actions on the skeleton.

Authors:  Shoshana Yakar; Haim Werner; Clifford J Rosen
Journal:  J Mol Endocrinol       Date:  2018-04-06       Impact factor: 5.098

5.  The Association Between IGF-I and IGFBP-3 and Incident Diabetes in an Older Population of Men and Women in the Cardiovascular Health Study.

Authors:  Chino S Aneke-Nash; Xiaonan Xue; Qibin Qi; Mary L Biggs; Anne Cappola; Lewis Kuller; Michael Pollak; Bruce M Psaty; David Siscovick; Kenneth Mukamal; Howard D Strickler; Robert C Kaplan
Journal:  J Clin Endocrinol Metab       Date:  2017-12-01       Impact factor: 5.958

Review 6.  The Spectrum of Fundamental Basic Science Discoveries Contributing to Organismal Aging.

Authors:  Joshua N Farr; Maria Almeida
Journal:  J Bone Miner Res       Date:  2018-08-13       Impact factor: 6.741

Review 7.  Extending lifespan by modulating the growth hormone/insulin-like growth factor-1 axis: coming of age.

Authors:  Silvana Duran-Ortiz; Edward O List; Reetobrata Basu; John J Kopchick
Journal:  Pituitary       Date:  2021-01-18       Impact factor: 4.107

8.  Disparate Central and Peripheral Effects of Circulating IGF-1 Deficiency on Tissue Mitochondrial Function.

Authors:  Gavin Pharaoh; Daniel Owen; Alexander Yeganeh; Pavithra Premkumar; Julie Farley; Shylesh Bhaskaran; Nicole Ashpole; Michael Kinter; Holly Van Remmen; Sreemathi Logan
Journal:  Mol Neurobiol       Date:  2019-11-15       Impact factor: 5.590

9.  Induction of somatopause in adult mice compromises bone morphology and exacerbates bone loss during aging.

Authors:  Manisha Dixit; Silvana Duran-Ortiz; Godze Yildirim; Sher Bahadur Poudel; Leeann D Louis; Andrzej Bartke; Mitchell B Schaffler; John J Kopchick; Shoshana Yakar
Journal:  Aging Cell       Date:  2021-11-23       Impact factor: 9.304

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.